The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 15, 2019
Filed:
May. 24, 2012
Daniel H. Zimmerman, Bethesda, MD (US);
Eyal Talor, Baltimore, MD (US);
Kanta Subbarao, Washington, DC (US);
Kobporn Boonnak, Bangkok, TH;
Daniel H. Zimmerman, Bethesda, MD (US);
Eyal Talor, Baltimore, MD (US);
Kanta Subbarao, Washington, DC (US);
Kobporn Boonnak, Bangkok, TH;
Cel-Sci Corp., Vienna, VA (US);
Abstract
The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment or prevention of influenza virus and other infectious diseases. Compositions containing the same, methods for producing the same, and methods for using the same are also disclosed, wherein the peptide constructs have the formula P-x-P, where Pis a peptide associated with an infectious agent and Pis a peptide that will bind to a class of immune cells, such as dendritic cells. The peptide construct can cause the maturation of immature dendritic cells to a more mature state. The peptide construct or the more mature dendritic cell can be administered to a subject to modulate or initiate an immune response against an infectious agent. Dyes, radioisotopes, or therapeutic agents conjugated with the dendritic cells can be used for localization of the immune target and/or prophylactic or therapeutic treatment of the disease.